Glycerin

Glycerin

SCHEMBL6753203

OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
ALDH1A1 P00352 1/20 1.00
THRB P10828 1/20 0.57
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
TSHR P16473 1/20 0.39
OR51E2 Q9H255 1/20 0.35
AKR1B1 P15121 1/20 0.35
USP2 O75604 2/20 0.32
CYP3A4 P08684 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CSNK2A1 P68400 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL29907853 1.00
Glycerin SCHEMBL3418854 1.00 LMNA (1.00) LMNAALDH1A1THRBTDP1L3MBTL1
Glycerin SCHEMBL797 1.00
Glycerin SCHEMBL14278795 1.00
Glycerin SCHEMBL5610362 1.00 LMNA (1.00) LMNAALDH1A1THRBTDP1L3MBTL1
Glycerin SCHEMBL8080917 1.00 LMNA (1.00) LMNAALDH1A1THRBTDP1L3MBTL1
Glycerin SCHEMBL9439059 1.00 LMNA (1.00) LMNAALDH1A1THRBTDP1L3MBTL1
Glycerin SCHEMBL14278797 1.00
Glycerin SCHEMBL10453101 1.00 LMNA (1.00) LMNAALDH1A1THRBTDP1L3MBTL1
Glycerin SCHEMBL29500430 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137614-A1 ANHYDROUS COMPOSITION FOR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2026-05-21 US claimed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 EP claimed
US-12433827-B2 Foamable cleansing compositions DEB IP LIMITED (GB) 2025-10-07 US claimed
EP-4604917-A1 ANHYDROUS COMPOSITION FOR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2025-08-27 EP claimed
WO-2025131147-A1 METHOD FOR ENRICHING A POLYGLYCEROL FATTY ACID ESTER WITH A DEFINED DEGREE OF ESTERIFICATION AND POLYMERIZATION IOI OLEO GMBH (DE) 2025-06-26 WO claimed
CN-119857053-A Double-layer emulsion containing glycolipid 珀莱雅化妆品股份有限公司 2025-04-22 CN claimed
CN-119679663-A Skin brightening liquid and preparation method thereof 广州樊文花化妆品有限公司 2025-03-25 CN claimed
US-20250041175-A1 COMPOSITION FOR SMOOTHING THE SKIN AND/OR THE LIPS L V M H RECHERCHE (FR) 2025-02-06 US claimed
WO-2024256375-A1 ANHYDROUS COMPOSITION COMPRISING A COMBINATION OF POLYGLYCEROLS L V M H RECHERCHE (FR) 2024-12-19 WO claimed
CN-115279185-B Micelle disinfectant 瑞士康特股份有限公司 2024-12-06 CN claimed
US-20230098760-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE FIRMENICH SA (CH) 2023-03-30 US claimed
EP-4076362-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE Firmenich SA (CH) 2022-10-26 EP claimed
CN-115141688-A Cleaning agent 株式会社资生堂 2022-10-04 CN claimed
US-20220304914-A1 COATING COMPOSITIONS JPMORGAN CHASE BANK, N.A. 2022-09-29 US claimed
CN-114983867-A Mild natural-source cleansing oil and preparation method thereof 浙江宜格企业管理集团有限公司 2022-09-02 CN claimed
CN-112691052-B Pure natural high-stability polymethoxylated flavone nano-emulsion and preparation and application thereof 杭州诺莘科技有限责任公司 2022-08-09 CN claimed
CN-114728078-A Extracellular vesicles linked to molecules and uses thereof 科迪亚克生物科学公司 2022-07-08 CN claimed
US-20220175628-A1 FOAMABLE CLEANSING COMPOSITIONS DEB IP LIMITED (GB) 2022-06-09 US claimed
CN-114366686-A Surface treatment powder and preparation method and application thereof 上海蔻沣生物科技有限公司 2022-04-19 CN claimed
EP-3979979-A1 COATING COMPOSITIONS Coty Inc. (US) 2022-04-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175628-A1 FOAMABLE CLEANSING COMPOSITIONS UGCG, GBA1, GBA2 LMNA 3126/4885ALDH1A1 1321/4885THRB 4011/4885
US-20220304914-A1 COATING COMPOSITIONS OR10J3, OR51E2, TAS2R20 LMNA 3674/4885ALDH1A1 1655/4885THRB 3352/4885
US-20260137614-A1 ANHYDROUS COMPOSITION FOR MAKING UP KERATIN MATERIALS KRT18, F12, DEGS1 LMNA 705/4885ALDH1A1 3941/4885THRB 306/4885
US-12433827-B2 Foamable cleansing compositions UGCG, GBA1, GBA2 LMNA 3126/4885ALDH1A1 1321/4885THRB 4011/4885
US-20230098760-A1 FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE TRPC5, TRPA1, CYP3A5 LMNA 3179/4885ALDH1A1 593/4885THRB 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.